tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS

Syros Pharmaceuticals (SYRS) Stock Investors

656 Followers
Based on 706,017 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SYRS
On average, investors allocate 4.23% of their portfolios to SYRS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 706,017 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SYRS

2.5%
Last 7
Days
0.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SYRS, out of 706,017 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SYRS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.35%
$3.82
Based on the activity of 12,978 investors who made their portfolios public
The table shows changes in SYRS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SYRS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.37%
-0.50%
-4.14%
255.02M
Healthcare
Micron
5.54%
-0.07%
+0.11%
80.72B
Technology
ChargePoint Holdings
3.92%
-0.54%
-0.65%
738.11M
Consumer Cyclical
AMC Entertainment
5.33%
-0.67%
-1.79%
1.35B
Communication Services
Block
4.58%
+0.38%
+1.97%
41.76B
Technology
Snap
9.88%
-0.84%
-2.96%
24.32B
Communication Services
Assertio Therapeutics
2.77%
-0.93%
-4.64%
104.14M
Healthcare
Plug Power
4.66%
-0.25%
-0.38%
2.42B
Industrials
Blink Charging Co
4.63%
>-0.01%
+1.84%
192.11M
Industrials
Li Auto
5.60%
+0.73%
+2.60%
35.98B
Consumer Cyclical
Based on the activity of 706,017 active portfolios
Open your Smart Portfolio

SYRS Investor Analysis

SYRS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.7%
of SYRS holders
are under 35
Average Segment Performance
Average P/E Ratio12.41
Beta8.46
Dividend Yield9.01%
SYRS investors between 35–55

Between 35–55

10.9%
Last 30 days
Holdings Change
58.2%
of SYRS holders
are between 35–55
Average Segment Performance
Average P/E Ratio8.58
Beta12.55
Dividend Yield10.27%
SYRS investors over 55

Over 55

3.1%
Last 30 days
Holdings Change
29.1%
of SYRS holders
are over 55
Average Segment Performance
Average P/E Ratio6.61
Beta5.67
Dividend Yield9.67%
Overview of age group and performance of SYRS stock investors
See who invests in SYRS according to age group and performance.

FAQ

How many retail Investors hold SYRS?
<0.1% of TipRank’s retail investors hold SYRS in their portfolios.
    What is SYRS Investor Sentiment?
    SYRS’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of SYRS in the last 7 days?
      ▲ 2.5% of TipRank’s retail investors changed their holding of SYRS in the last 7 days.
        What percentage of retail investors changed their holding of SYRS in the last 30 days?
        ▼ 0.5% of TipRank’s retail investors changed their holding of SYRS in the last 30 days.
          What is the average age of retail investors who hold SYRS?
          The average age of SYRS Holders is between 35–55.
            What other stocks have SYRS investors also bought?
            SYRS Investors also bought CHRS, MU, CHPT, AMC, SQ, SNAP, ASRT, PLUG, BLNK, LI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis